Rajesh Kothari, Managing Director at AlfAccurate Advisors said investors should focus on the business cycle and visibility of fresh orders over the next three to…
India’s quick commerce race is intensifying, with Blinkit, Zepto and Swiggy Instamart competing for dominance. Blinkit leads in orders, revenue, dark store count and is…
Cipla said the USFDA has classified its April inspection of the company’s Goa manufacturing facility as Voluntary Action Indicated (VAI), a status under which observations…
One of the biggest drags on the benchmark indices was the IT sector. The Nifty IT index extended its losing streak to seven straight sessions,…
NLC India signs MoU with CSIR-CECRI to develop tech for extracting rare earths from mine waste, supporting India’s critical minerals self-reliance mission.
MTAR Technologies shares fell after Crusoe Energy paused a 1.8 GW data centre project that was expected to deploy 900 MW of Bloom Energy fuel…
With the latest approval, Alembic Pharma’s cumulative USFDA tally stands at 241 ANDA approvals, comprising 221 final approvals and 20 tentative approvals.
Sanjay Parekh of Sohum Asset Managers sees potential in CarTrade Tech, large private banks and select infrastructure plays. While he remains constructive on India’s manufacturing…
Hetal Dalal, President & COO of IiAS and Shriram Subramanian, Founder & MD of InGovern why investors may demand greater clarity on the use of…
Ankur Rudra, Head of APAC Telecoms & India TMT Research at JPMorgan, expects first-quarter growth estimates to be lowered by 0.5-1 percentage point, which points…